<DOC>
	<DOCNO>NCT00121069</DOCNO>
	<brief_summary>This pilot study design ass efficacy escitalopram treatment specific phobia adult outpatient .</brief_summary>
	<brief_title>Study Escitalopram Treatment Specific Phobia</brief_title>
	<detailed_description>This double-blind placebo-controlled pilot trial study design ass efficacy 12 week escitalopram vs. placebo treatment specific phobia adult outpatient . It hypothesize escitalopram safe effective treatment specific phobia .</detailed_description>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Adults 1865 year age DSMIV criterion specific phobia accord MINI For woman childbearing potential , negative serum pregnancy test screen Written informed consent Any current primary DSMIV diagnosis specific phobia History DSMIV substance abuse dependence within last month Lifetime history bipolar I disorder , schizophrenia psychotic disorder , mental retardation , pervasive developmental disorder cognitive disorder due general medical condition Suicide risk serious suicide attempt within last year Clinically significant laboratory EKG abnormality unstable medical condition For woman childbearing potential , unwillingness use acceptable form contraception study Subjects need concurrent use psychotropic medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>specific phobia</keyword>
	<keyword>anxiety</keyword>
	<keyword>SSRI</keyword>
	<keyword>clinical trial</keyword>
	<keyword>escitalopram</keyword>
</DOC>